Le Lézard
Classified in: Covid-19 virus
Subject: Product/Service

Lianhua Qingwen Selected as Recommended Medicine in China's Diagnosis and Treatment Protocol for COVID-19

Recently, China's National Health Commission and State Administration of Traditional Chinese Medicine jointly-published The Diagnosis and Treatment Protocol for COVID-19 (Trial Version 8), recommending that Lianhua Qingwen Capsule, a Chinese traditional medicine, be used during the medical observation period of COVID-19 patients.

Lianhua Qingwen's selection to the protocol demonstrates the recognition from Chinese authorities of its outstanding performance to control COVID-19 in China. It is learned that during the pandemic, Lianhua Qingwen has been widely used in designated hospitals and medical institutions in China, and has become the most recommended Chinese medicine in the COVID-19 treatment programs from the country's provinces and municipalities.

This is not the first time that Lianhua Qingwen came into public view as an official recommended medicine in China. In 2003, Lianhua Qingwen was developed by Yiling Pharmaceutical in response to the "SARS" pandemic. Research of its effect on SARS from the Academy of Military Medical Sciences in China has revealed that it could significantly inhibit the replication of SARS virus. In 2015 when another coronavirus caused the Middle East respiratory syndrome, the National Health Commission also explicitly recommended Lianhua Qingwen Capsule as the preventive medical treatment medicine in its plan.

Lianhua Qingwen Capsule has recently been approved by the Food and Drug Administration of the Philippines and entered the Philippine market on November 23. In view of its crucial role played in major public health events, the Philippine experts hope that Lianhua Qingwen will be helpful to effectively combat COVID-19 in Philippines after entering the market and provide assistance for the Philippine government and people.

These press releases may also interest you

at 06:35
Gannett Co., Inc. ("Gannett", "we", "us", "our", or the "Company") today reported its preliminary financial results for the fourth quarter ended December 31, 2020. Selected, Preliminary Financial Results Unaudited; in millions Preliminary...

at 06:35
Capstone Mining Corp. ("Capstone" or the "Company") provides a corporate update including 2021 production and capital guidance, project and exploration updates and executive leadership announcements. Capstone's 2020 actual production finished above...

at 06:35
Coherent, Inc. , one of the world's leading providers of lasers, laser-based technologies and laser-based system solutions in a broad range of scientific, commercial and industrial applications, today announced preliminary financial results for its...

at 06:31
Lumentum Holdings Inc. ("Lumentum" or the "Company") today reported preliminary results for its fiscal second quarter of 2021 ended December 26, 2020. Preliminary Results for the Fiscal Second Quarter 2021 Net revenue of approximately $478.8...

at 06:30
The "Global Prepared Food Equipment Market by Type (Pre-processing, Processing, Packaging), Application (Snack & Savory Products, Meat & Seafood Products), Mode of Operation (Automatic, Semi-automatic, Manual), and Region - Forecast to 2026" report...

at 06:30
Montage Gold Corp. ("Montage" or the "Company") is pleased to report the final results of its Phase 1 resource expansion drill program at the Morondo Gold Project ("MGP") in Côte d'Ivoire. "The completion of the Phase 1 expansion drill campaign...

News published on 4 december 2020 at 22:05 and distributed by: